精密ゲノム検査の市場規模、シェア、動向分析レポート：製品・サービス別、用途別、技術別、地域別、セグメント別予測、2025年～2030年

精密ゲノム検査市場動向

精密ゲノム検査の世界市場規模は2024年に154億9,000万米ドルと推定され、ゲノム技術の進歩と個別化医療の重視の高まりにより、2025～2030年にかけてCAGR 14.80％で成長すると予測されています。

この市場には、遺伝子情報の分析に使用されるさまざまな診断ツールや技術が含まれ、より正確な診断、的を絞った治療、患者の転帰の改善につながります。精密ゲノム検査の需要は、疾患の早期発見、効果的な治療計画、慢性疾患のより良い管理の必要性によって牽引されています。

CRISPR-Cas9ゲノム編集技術に牽引される精密ゲノム検査は、継続的な技術革新と研究開発への投資の増加によって勢いを増しています。その結果、市場は今後数年間で力強く拡大する態勢を整えています。例えば、2024年3月、The Advanced Genomics Collaboration（TAGC）は、メルボルン大学が主導し、メルボルン・バイオメディカル・プレシクト全体の事業体と連携した4つのイノベーションプロジェクトに資金を授与しました。これらのプロジェクトは、ビクトリア州投資庁の支援により、メルボルン大学と世界のバイオテクノロジー企業であるイルミナの協力により実現した、TAGCの世界トップクラスのゲノミクス・ハブで最先端のDNAシーケンス技術を利用することもできます。

遺伝性疾患や慢性疾患の増加により、精密ゲノム検査の需要が高まっています。世界保健機関（WHO）によると、単一の遺伝子の変異に起因する単一遺伝子疾患は推定1万種類あり、1,000人中約10人が罹患しています。これは、世界中で7,000万人から8,000万人近くがこのような疾患を抱えていることになります。嚢胞性線維症、ハンチントン病、様々ながんのような疾患は、患者の健康と生活の質に大きな影響を与えます。効果的な治療と管理には、早期かつ正確な診断が不可欠です。精密ゲノム検査は、疾患の原因となる遺伝子変異の同定を可能にし、タイムリーな介入と個別化された治療計画を可能にします。このような疾患の発生率が上昇を続ける中、信頼性が高く包括的なゲノム検査ソリューションの必要性が市場成長の原動力となります。

さらに、学術機関、研究機関、医療プロバイダー、バイオテクノロジー企業間の連携が市場拡大を加速しています。こうしたパートナーシップは、知識の交換、リソースの共有、技術の進歩を促進することでイノベーションを促進します。製薬企業との戦略的提携は、精密ゲノム検査を医薬品開発と個別化医療にさらに統合します。協力的なエコシステムが成長するにつれ、精密ゲノム検査産業は持続的な成長を遂げると予想されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 精密ゲノム検査市場の変数、動向、範囲

• 市場系統の展望
  • 親市場の展望
  • 関連/補助的な市場展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 精密ゲノム検査市場分析ツール
  • 産業分析-ポーターのファイブフォース分析
  • PESTEL分析
  • COVID-19の影響分析
• ゲノム検査コスト分析
• ゲノム検査におけるAI用途

第4章 精密ゲノム検査市場：製品・サービス、推定・動向分析

• セグメントダッシュボード
• 世界の精密ゲノム検査市場の製品・サービスの変動分析
• 世界の精密ゲノム検査市場規模と動向分析、製品・サービス別、2018～2030年
• 消耗品
  • キット
  • 試薬
• 装置
• サービス

第5章 精密ゲノム検査市場：用途別、推定・動向分析

• セグメントダッシュボード
• 世界の精密ゲノム検査市場の用途変動分析
• 世界の精密ゲノム検査市場規模と動向分析、用途別、2018～2030年
• 腫瘍学
• 心血管疾患
• 神経疾患
• リプロダクティブヘルス
• 希少疾患
• その他

第6章 精密ゲノム検査市場：技術別、推定・動向分析

• セグメントダッシュボード
• 世界の精密ゲノム検査市場の技術変動分析
• 世界の精密ゲノム検査市場規模と動向分析、技術別、2018～2030年
• 次世代シーケンス
• ポリメラーゼ連鎖反応
• マイクロアレイ技術
• サンガーシーケンス
• CRISPR/Casシステム
• その他

第7章 精密ゲノム検査市場：最終用途別、推定・動向分析

• セグメントダッシュボード
• 世界の精密ゲノム検査市場の最終用途変動分析
• 世界の精密ゲノム検査市場規模と動向分析、最終用途別、2018～2030年
• 病院とクリニック
• 診断ラボ
• 研究・学術機関
• その他

第8章 精密ゲノム検査市場：製品・サービス、用途、技術、最終用途による地域別、推定・動向分析

• 地域別市場シェア分析、2024年と2030年
• 地域別市場ダッシュボード
• 市場規模と予測動向分析、2018～2030年
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第9章 競合情勢

• 企業分類
• 戦略マッピング
• 企業市況分析、2024年
• Competitive Scenario
• 企業プロファイル/上場企業
  • Danaher
  • Merck KGaA
  • Revvity, Inc.
  • Maravai LifeSciences
  • GenScript
  • QIAGEN
  • PacBio
  • Oxford Nanopore Technologies plc.
  • Illumina, Inc.
  • 10x Genomics, Inc.

List of Tables

• Table 1 List of abbreviation
• Table 2 Global precision genomic testing market, by region, 2018 - 2030 (USD Billion)
• Table 3 Global precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
• Table 4 Global precision genomic testing market, by application, 2018 - 2030 (USD Billion)
• Table 5 Global precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
• Table 6 Global precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
• Table 7 North America precision genomic testing market, by country, 2018 - 2030 (USD Billion)
• Table 8 North America precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
• Table 9 North America precision genomic testing market, by application, 2018 - 2030 (USD Billion)
• Table 10 North America precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
• Table 11 North America precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
• Table 12 U.S. precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
• Table 13 U.S. precision genomic testing market, by application, 2018 - 2030 (USD Billion)
• Table 14 U.S. precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
• Table 15 U.S. precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
• Table 16 Canada precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
• Table 17 Canada precision genomic testing market, by application, 2018 - 2030 (USD Billion)
• Table 18 Canada precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
• Table 19 Canada precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
• Table 20 Mexico precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
• Table 21 Mexico precision genomic testing market, by application, 2018 - 2030 (USD Billion)
• Table 22 Mexico precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
• Table 23 Mexico precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
• Table 24 Europe precision genomic testing market, by country, 2018 - 2030 (USD Billion)
• Table 25 Europe precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
• Table 26 Europe precision genomic testing market, by application, 2018 - 2030 (USD Billion)
• Table 27 Europe precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
• Table 28 Europe precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
• Table 29 UK precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
• Table 30 UK precision genomic testing market, by application, 2018 - 2030 (USD Billion)
• Table 31 UK precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
• Table 32 UK precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
• Table 33 Germany precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
• Table 34 Germany precision genomic testing market, by application, 2018 - 2030 (USD Billion)
• Table 35 Germany precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
• Table 36 Germany precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
• Table 37 France precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
• Table 38 France precision genomic testing market, by application, 2018 - 2030 (USD Billion)
• Table 39 France precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
• Table 40 France precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
• Table 41 Italy precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
• Table 42 Italy precision genomic testing market, by application, 2018 - 2030 (USD Billion)
• Table 43 Italy precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
• Table 44 Italy precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
• Table 45 Spain precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
• Table 46 Spain precision genomic testing market, by application, 2018 - 2030 (USD Billion)
• Table 47 Spain precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
• Table 48 Spain precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
• Table 49 Denmark precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
• Table 50 Denmark precision genomic testing market, by application, 2018 - 2030 (USD Billion)
• Table 51 Denmark precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
• Table 52 Denmark precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
• Table 53 Sweden precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
• Table 54 Sweden precision genomic testing market, by application, 2018 - 2030 (USD Billion)
• Table 55 Sweden precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
• Table 56 Sweden precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
• Table 57 Norway precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
• Table 58 Norway precision genomic testing market, by application, 2018 - 2030 (USD Billion)
• Table 59 Norway precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
• Table 60 Norway precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
• Table 61 Asia Pacific precision genomic testing market, by country, 2018 - 2030 (USD Billion)
• Table 62 Asia Pacific precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
• Table 63 Asia Pacific precision genomic testing market, by application, 2018 - 2030 (USD Billion)
• Table 64 Asia Pacific precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
• Table 65 Asia Pacific precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
• Table 66 Japan precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
• Table 67 Japan precision genomic testing market, by application, 2018 - 2030 (USD Billion)
• Table 68 Japan precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
• Table 69 Japan precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
• Table 70 China precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
• Table 71 China precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
• Table 72 China precision genomic testing market, by application, 2018 - 2030 (USD Billion)
• Table 73 China precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
• Table 74 India precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
• Table 75 India precision genomic testing market, by application, 2018 - 2030 (USD Billion)
• Table 76 India precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
• Table 77 India precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
• Table 78 Australia precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
• Table 79 Australia precision genomic testing market, by application, 2018 - 2030 (USD Billion)
• Table 80 Australia precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
• Table 81 Australia precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
• Table 82 South Korea precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
• Table 83 South Korea precision genomic testing market, by application, 2018 - 2030 (USD Billion)
• Table 84 South Korea precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
• Table 85 South Korea precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
• Table 86 Thailand precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
• Table 87 Thailand precision genomic testing market, by application, 2018 - 2030 (USD Billion)
• Table 88 Thailand precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
• Table 89 Thailand precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
• Table 90 Latin America precision genomic testing market, by country, 2018 - 2030 (USD Billion)
• Table 91 Latin America precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
• Table 92 Latin America precision genomic testing market, by application, 2018 - 2030 (USD Billion)
• Table 93 Latin America precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
• Table 94 Latin America precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
• Table 95 Brazil precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
• Table 96 Brazil precision genomic testing market, by application, 2018 - 2030 (USD Billion)
• Table 97 Brazil precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
• Table 98 Brazil precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
• Table 99 Argentina precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
• Table 100 Argentina precision genomic testing market, by application, 2018 - 2030 (USD Billion)
• Table 101 Argentina precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
• Table 102 Argentina precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
• Table 103 MEA precision genomic testing market, by country, 2018 - 2030 (USD Billion)
• Table 104 MEA precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
• Table 105 MEA precision genomic testing market, by application, 2018 - 2030 (USD Billion)
• Table 106 MEA precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
• Table 107 MEA precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
• Table 108 South Africa precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
• Table 109 South Africa precision genomic testing market, by application, 2018 - 2030 (USD Billion)
• Table 110 South Africa precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
• Table 111 South Africa precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
• Table 112 Saudi Arabia precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
• Table 113 Saudi Arabia precision genomic testing market, by application, 2018 - 2030 (USD Billion)
• Table 114 Saudi Arabia precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
• Table 115 Saudi Arabia precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
• Table 116 UAE precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
• Table 117 UAE precision genomic testing market, by application, 2018 - 2030 (USD Billion)
• Table 118 UAE precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
• Table 119 UAE precision genomic testing market, by end use, 2018 - 2030 (USD Billion)
• Table 120 Kuwait precision genomic testing market, by product & service, 2018 - 2030 (USD Billion)
• Table 121 Kuwait precision genomic testing market, by application, 2018 - 2030 (USD Billion)
• Table 122 Kuwait precision genomic testing market, by technology, 2018 - 2030 (USD Billion)
• Table 123 Kuwait precision genomic testing market, by end use, 2018 - 2030 (USD Billion)

List of Figures

• Fig. 1 Precision genomic testing market segmentation
• Fig. 2 Data analysis models
• Fig. 3 Market formulation and validation
• Fig. 4 Data validating & publishing
• Fig. 5 Market research process
• Fig. 6 Information procurement
• Fig. 7 Primary research
• Fig. 8 Value-chain-based sizing & forecasting
• Fig. 9 QFD modelling for market share assessment
• Fig. 10 Market formulation & validation
• Fig. 11 Commodity flow analysis
• Fig. 12 Market outlook
• Fig. 13 Segment snapshot-1
• Fig. 14 Segment snapshot-2
• Fig. 15 Competitive landscape snapshot
• Fig. 16 Market trends & outlook
• Fig. 17 Porter's five force analysis
• Fig. 18 PESTEL analysis
• Fig. 19 Precision genomic testing market: Product & service outlook key takeaways
• Fig. 20 Precision genomic testing market: Product & service movement analysis
• Fig. 21 Consumables market estimates and forecasts, 2018 - 2030 (USD billion)
• Fig. 22 Kits market estimates and forecasts, 2018 - 2030 (USD billion)
• Fig. 23 Plasmids market estimates and forecasts, 2018 - 2030 (USD billion)
• Fig. 24 Reagents market estimates and forecasts, 2018 - 2030 (USD billion)
• Fig. 25 Equipment market estimates and forecasts, 2018 - 2030 (USD billion)
• Fig. 26 Services market estimates and forecasts, 2018 - 2030 (USD billion)
• Fig. 27 Precision genomic testing market: Application outlook key takeaways
• Fig. 28 Precision genomic testing market: Application movement analysis
• Fig. 29 Oncology market estimates and forecasts, 2018 - 2030 (USD billion)
• Fig. 30 Cardiovascular diseases market estimates and forecasts, 2018 - 2030 (USD billion)
• Fig. 31 Neurological disorders market estimates and forecasts, 2018 - 2030 (USD billion)
• Fig. 32 Reproductive health market estimates and forecasts, 2018 - 2030 (USD billion)
• Fig. 33 Rare diseases market estimates and forecasts, 2018 - 2030 (USD billion)
• Fig. 34 Others market estimates and forecasts, 2018 - 2030 (USD billion)
• Fig. 35 Precision genomic testing market: Technology outlook key takeaways
• Fig. 36 Precision genomic testing market: Technology movement analysis
• Fig. 37 Next-generation sequencing market estimates and forecasts, 2018 - 2030 (USD billion)
• Fig. 38 Polymerase chain reaction market estimates and forecasts, 2018 - 2030 (USD billion)
• Fig. 39 Microarray technology market estimates and forecasts, 2018 - 2030 (USD billion)
• Fig. 40 Sanger sequencing market estimates and forecasts, 2018 - 2030 (USD billion)
• Fig. 41 CRISPR/Cas systems market estimates and forecasts, 2018 - 2030 (USD billion)
• Fig. 42 Others market estimates and forecasts, 2018 - 2030 (USD billion)
• Fig. 43 Precision genomic testing market: End Use outlook key takeaways
• Fig. 44 Precision genomic testing market: End Use movement analysis
• Fig. 45 Hospitals and clinics market estimates and forecasts, 2018 - 2030 (USD billion)
• Fig. 46 Diagnostic laboratories market estimates and forecasts, 2018 - 2030 (USD billion)
• Fig. 47 Research & academic institutes companies market estimates and forecasts, 2018 - 2030 (USD billion)
• Fig. 48 Others market estimates and forecasts, 2018 - 2030 (USD billion)
• Fig. 49 Regional marketplace outlook, 2024 & 2030 (USD billion)
• Fig. 50 Regional marketplace: Key takeaways
• Fig. 51 North America precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
• Fig. 52 Key country dynamics
• Fig. 53 U.S. precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
• Fig. 54 Key country dynamics
• Fig. 55 Canada precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
• Fig. 56 Key country dynamics
• Fig. 57 Mexico precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
• Fig. 58 Europe precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
• Fig. 59 Key country dynamics
• Fig. 60 UK precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
• Fig. 61 Key country dynamics
• Fig. 62 Germany precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
• Fig. 63 Key country dynamics
• Fig. 64 France precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
• Fig. 65 Key country dynamics
• Fig. 66 Spain precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
• Fig. 67 Key country dynamics
• Fig. 68 Italy precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
• Fig. 69 Key country dynamics
• Fig. 70 Denmark precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
• Fig. 71 Key country dynamics
• Fig. 72 Sweden precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
• Fig. 73 Key country dynamics
• Fig. 74 Norway precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
• Fig. 75 Asia Pacific precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
• Fig. 76 Key country dynamics
• Fig. 77 Japan precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
• Fig. 78 Key country dynamics
• Fig. 79 China precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
• Fig. 80 Key country dynamics
• Fig. 81 India precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
• Fig. 82 Key country dynamics
• Fig. 83 Australia precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
• Fig. 84 Key country dynamics
• Fig. 85 South Korea precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
• Fig. 86 Key country dynamics
• Fig. 87 Thailand precision genomic testing market estimates and forecasts, 2018 - 2030 (USD billion)
• Fig. 88 Key country dynamics
• Fig. 89 Market participant categorization
• Fig. 90 Precision genomic testing market position analysis, 2024
• Fig. 91 Strategic framework

Precision Genomic Testing Market Trends:

The global precision genomic testing market size was estimated at USD 15.49 billion in 2024 and is projected to grow at a CAGR of 14.80% from 2025 to 2030, due to advancements in genomic technologies and an increasing emphasis on personalized medicine. This market encompasses a range of diagnostic tools and techniques used to analyze genetic information, leading to more accurate diagnoses, targeted therapies, and improved patient outcomes. The demand for precision genomic testing is driven by the need for early disease detection, effective treatment planning, and better management of chronic conditions.

Precision genomic testing, driven by CRISPR-Cas9 genome editing technology, is gaining momentum with continuous innovations and increasing investment in research and development. As a result, the market is poised for robust expansion in the coming years. For instance, in March 2024, The Advanced Genomics Collaboration (TAGC) awarded funding to four Innovation Projects led by the University of Melbourne in partnership with entities across the Melbourne Biomedical Precinct. These projects will also benefit from access to cutting-edge DNA sequencing technology at TAGC's world-class genomics hub, made possible through a collaboration between the University and global biotech firm Illumina, with backing from Invest Victoria.

The rising prevalence of genetic disorders and chronic diseases is driving the demand for precision genomic testing. An estimated 10,000 single-gene diseases result from mutations in a single gene, affecting approximately 10 out of every 1,000 people, according to the World Health Organization. This translates to nearly 70-80 million individuals worldwide living with such conditions. Disorders like cystic fibrosis, Huntington's disease, and various cancers significantly impact on patient health and quality of life. Early and accurate diagnosis is essential for effective treatment and management. Precision genomic testing enables the identification of disease-causing genetic mutations, allowing for timely interventions and personalized treatment plans. As the incidence of these conditions continues to rise, the need for reliable and comprehensive genomic testing solutions will drive market growth.

Additionally, collaborations among academic institutions, research organizations, healthcare providers, and biotechnology companies are accelerating market expansion. These partnerships foster innovation by facilitating knowledge exchange, resource sharing, and technological advancements. Strategic alliances with pharmaceutical firms further integrate precision genomic testing into drug development and personalized medicine. As the collaborative ecosystem grows, the precision genomic testing industry is expected to see sustained growth.

Global Precision Genomic Testing Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global precision genomic testing market report based on product & service, application, technology, end use, and region:

• Product & Service Outlook (Revenue, USD Billion, 2018 - 2030)
• Consumables
  • Kits
  • Reagents
• Equipment
• Services
• Application Outlook (Revenue, USD Billion, 2018 - 2030)
• Oncology
• Cardiovascular Diseases
• Neurological Disorders
• Reproductive Health
• Rare Diseases
• Others
• Technology Outlook (Revenue, USD Billion, 2018 - 2030)
• Next-Generation Sequencing
• Polymerase Chain Reaction
• Microarray Technology
• Sanger Sequencing
• CRISPR/Cas Systems
• Others
• End Use Outlook (Revenue, USD Billion, 2018 - 2030)
• Hospitals & Clinics
• Diagnostic Laboratories
• Research & Academic Institutes
• Others
• Regional Outlook (Revenue, USD Billion, 2018 - 2030)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Product & Service Segment
  • 1.2.2. Application Segment
  • 1.2.3. Technology Segment
  • 1.2.4. End Use Segment
• 1.3. Information analysis
  • 1.3.1. Market formulation & data visualization
• 1.4. Data validation & publishing
• 1.5. Information Procurement
  • 1.5.1. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
• 1.9. Total Market: CAGR Calculation
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Insights Landscape

Chapter 3. Precision Genomic Testing Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising demand for personalized medicine
    • 3.2.1.2. Advancements in genomic testing technology
    • 3.2.1.3. Increasing government funding & growing focus on genomic studies
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Ethical and safety concerns related to precision genomic testing technologies
• 3.3. Precision Genomic Testing Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis
• 3.4. Genomic Testing Cost Analysis
• 3.5. AI Applications in Genomic Testing

Chapter 4. Precision Genomic Testing Market: Product & Service Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Precision Genomic Testing Market Product & Service Movement Analysis
• 4.3. Global Precision Genomic Testing Market Size & Trend Analysis, by Product & Service, 2018 to 2030 (USD Billion)
• 4.4. Consumables
  • 4.4.1. Consumables market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 4.4.2. Kits
    • 4.4.2.1. Kits market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 4.4.3. Reagents
    • 4.4.3.1. Reagents market estimates and forecasts, 2018 to 2030 (USD Billion)
• 4.5. Equipment
  • 4.5.1. Equipment market estimates and forecasts, 2018 to 2030 (USD Billion)
• 4.6. Services
  • 4.6.1. Services market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 5. Precision Genomic Testing Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Precision Genomic Testing Market Application Movement Analysis
• 5.3. Global Precision Genomic Testing Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Billion)
• 5.4. Oncology
  • 5.4.1. Oncology market estimates and forecasts, 2018 to 2030 (USD Billion)
• 5.5. Cardiovascular Diseases
  • 5.5.1. Cardiovascular diseases market estimates and forecasts, 2018 to 2030 (USD Billion)
• 5.6. Neurological Disorders
  • 5.6.1. Neurological disorders market estimates and forecasts, 2018 to 2030 (USD Billion)
• 5.7. Reproductive Health
  • 5.7.1. Reproductive health market estimates and forecasts, 2018 to 2030 (USD Billion)
• 5.8. Rare Diseases
  • 5.8.1. Rare diseases market estimates and forecasts, 2018 to 2030 (USD Billion)
• 5.9. Others
  • 5.9.1. Others market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 6. Precision Genomic Testing Market: Technology Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Precision Genomic Testing Market Technology Movement Analysis
• 6.3. Global Precision Genomic Testing Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Billion)
• 6.4. Next-Generation Sequencing
  • 6.4.1. Next-generation sequencing market estimates and forecasts, 2018 to 2030 (USD Billion)
• 6.5. Polymerase Chain Reaction
  • 6.5.1. Polymerase chain reaction market estimates and forecasts, 2018 to 2030 (USD Billion)
• 6.6. Microarray Technology
  • 6.6.1. Microarray technology market estimates and forecasts, 2018 to 2030 (USD Billion)
• 6.7. Sanger Sequencing
  • 6.7.1. Sanger sequencing market estimates and forecasts, 2018 to 2030 (USD Billion)
• 6.8. CRISPR/Cas Systems
  • 6.8.1. CRISPR/Cas systems market estimates and forecasts, 2018 to 2030 (USD Billion)
• 6.9. Others
  • 6.9.1. Others market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 7. Precision Genomic Testing Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Precision Genomic Testing Market End Use Movement Analysis
• 7.3. Global Precision Genomic Testing Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Billion)
• 7.4. Hospitals and Clinics
  • 7.4.1. Hospitals and clinics market estimates and forecasts, 2018 to 2030 (USD Billion)
• 7.5. Diagnostic Laboratories
  • 7.5.1. Diagnostic laboratories market estimates and forecasts, 2018 to 2030 (USD Billion)
• 7.6. Research & Academic Institutes
  • 7.6.1. Research & academic institutes market estimates and forecasts, 2018 to 2030 (USD Billion)
• 7.7. Others
  • 7.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 8. Precision Genomic Testing Market: Regional Estimates & Trend Analysis by Product & Service, Application, Technology, and End Use

• 8.1. Regional Market Share Analysis, 2024 & 2030
• 8.2. Regional Market Dashboard
• 8.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
• 8.4. North America
  • 8.4.1. North America market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 8.4.2. U.S.
    • 8.4.2.1. Key country dynamics
    • 8.4.2.2. Competitive scenario
    • 8.4.2.3. Regulatory framework
    • 8.4.2.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 8.4.3. Canada
    • 8.4.3.1. Key country dynamics
    • 8.4.3.2. Competitive scenario
    • 8.4.3.3. Regulatory framework
    • 8.4.3.4. Canada market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 8.4.4. Mexico
    • 8.4.4.1. Key country dynamics
    • 8.4.4.2. Competitive scenario
    • 8.4.4.3. Regulatory framework
    • 8.4.4.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Billion)
• 8.5. Europe
  • 8.5.1. Europe market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 8.5.2. UK
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Competitive scenario
    • 8.5.2.3. Regulatory framework
    • 8.5.2.4. UK market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 8.5.3. Germany
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Competitive scenario
    • 8.5.3.3. Regulatory framework
    • 8.5.3.4. Germany market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 8.5.4. France
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Competitive scenario
    • 8.5.4.3. Regulatory framework
    • 8.5.4.4. France market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 8.5.5. Italy
    • 8.5.5.1. Key country dynamics
    • 8.5.5.2. Competitive scenario
    • 8.5.5.3. Regulatory framework
    • 8.5.5.4. Italy market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 8.5.6. Spain
    • 8.5.6.1. Key country dynamics
    • 8.5.6.2. Competitive scenario
    • 8.5.6.3. Regulatory framework
    • 8.5.6.4. Spain market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 8.5.7. Denmark
    • 8.5.7.1. Key country dynamics
    • 8.5.7.2. Competitive scenario
    • 8.5.7.3. Denmark market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 8.5.8. Sweden
    • 8.5.8.1. Key country dynamics
    • 8.5.8.2. Competitive scenario
    • 8.5.8.3. Regulatory framework
    • 8.5.8.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 8.5.9. Norway
    • 8.5.9.1. Key country dynamics
    • 8.5.9.2. Competitive scenario
    • 8.5.9.3. Regulatory framework
    • 8.5.9.4. Norway market estimates and forecasts, 2018 to 2030 (USD Billion)
• 8.6. Asia Pacific
  • 8.6.1. Asia Pacific market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 8.6.2. Japan
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Competitive scenario
    • 8.6.2.3. Regulatory framework
    • 8.6.2.4. Japan market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 8.6.3. China
    • 8.6.3.1. Key country dynamics
    • 8.6.3.2. Competitive scenario
    • 8.6.3.3. Regulatory framework
    • 8.6.3.4. China market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 8.6.4. India
    • 8.6.4.1. Key country dynamics
    • 8.6.4.2. Competitive scenario
    • 8.6.4.3. Regulatory framework
    • 8.6.4.4. India market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 8.6.5. Australia
    • 8.6.5.1. Key country dynamics
    • 8.6.5.2. Competitive scenario
    • 8.6.5.3. Regulatory framework
    • 8.6.5.4. Australia market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 8.6.6. South Korea
    • 8.6.6.1. Key country dynamics
    • 8.6.6.2. Competitive scenario
    • 8.6.6.3. Regulatory framework
    • 8.6.6.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 8.6.7. Thailand
    • 8.6.7.1. Key country dynamics
    • 8.6.7.2. Competitive scenario
    • 8.6.7.3. Regulatory framework
    • 8.6.7.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Billion)
• 8.7. Latin America
  • 8.7.1. Latin America market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 8.7.2. Brazil
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Competitive scenario
    • 8.7.2.3. Regulatory framework
    • 8.7.2.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 8.7.3. Argentina
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Competitive scenario
    • 8.7.3.3. Regulatory framework
    • 8.7.3.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Billion)
• 8.8. MEA
  • 8.8.1. MEA market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 8.8.2. South Africa
    • 8.8.2.1. Key country dynamics
    • 8.8.2.2. Competitive scenario
    • 8.8.2.3. Regulatory framework
    • 8.8.2.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 8.8.3. Saudi Arabia
    • 8.8.3.1. Key country dynamics
    • 8.8.3.2. Competitive scenario
    • 8.8.3.3. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 8.8.4. UAE
    • 8.8.4.1. Key country dynamics
    • 8.8.4.2. Competitive scenario
    • 8.8.4.3. Regulatory framework
    • 8.8.4.4. UAE market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 8.8.5. Kuwait
    • 8.8.5.1. Key country dynamics
    • 8.8.5.2. Competitive scenario
    • 8.8.5.3. Regulatory framework
    • 8.8.5.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 9. Competitive Landscape

• 9.1. Company Categorization
• 9.2. Strategy Mapping
• 9.3. Company Market Position Analysis, 2024
• 9.4. Competitive Scenario
• 9.5. Company Profiles/Listing
  • 9.5.1. Danaher
    • 9.5.1.1. Company overview
    • 9.5.1.2. Financial performance
    • 9.5.1.3. Product & service benchmarking
    • 9.5.1.4. Strategic initiatives
  • 9.5.2. Merck KGaA
    • 9.5.2.1. Company overview
    • 9.5.2.2. Financial performance
    • 9.5.2.3. Product & service benchmarking
    • 9.5.2.4. Strategic initiatives
  • 9.5.3. Revvity, Inc.
    • 9.5.3.1. Company overview
    • 9.5.3.2. Financial performance
    • 9.5.3.3. Product & service benchmarking
    • 9.5.3.4. Strategic initiatives
  • 9.5.4. Maravai LifeSciences
    • 9.5.4.1. Company overview
    • 9.5.4.2. Financial performance
    • 9.5.4.3. Product & service benchmarking
    • 9.5.4.4. Strategic initiatives
  • 9.5.5. GenScript
    • 9.5.5.1. Company overview
    • 9.5.5.2. Financial performance
    • 9.5.5.3. Product & service benchmarking
    • 9.5.5.4. Strategic initiatives
  • 9.5.6. QIAGEN
    • 9.5.6.1. Company overview
    • 9.5.6.2. Financial performance
    • 9.5.6.3. Product & service benchmarking
    • 9.5.6.4. Strategic initiatives
  • 9.5.7. PacBio
    • 9.5.7.1. Company overview
    • 9.5.7.2. Financial performance
    • 9.5.7.3. Product & service benchmarking
    • 9.5.7.4. Strategic initiatives
  • 9.5.8. Oxford Nanopore Technologies plc.
    • 9.5.8.1. Company overview
    • 9.5.8.2. Financial performance
    • 9.5.8.3. Product & service benchmarking
    • 9.5.8.4. Strategic initiatives
  • 9.5.9. Illumina, Inc.
    • 9.5.9.1. Company overview
    • 9.5.9.2. Financial performance
    • 9.5.9.3. Product & service benchmarking
    • 9.5.9.4. Strategic initiatives
  • 9.5.10. 10x Genomics, Inc.
    • 9.5.10.1. Company overview
    • 9.5.10.2. Financial performance
    • 9.5.10.3. Product & service benchmarking
    • 9.5.10.4. Strategic initiatives